Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024.
西雅圖，2024年4月11日（GLOBE NEWSWIRE）——開創單分子蛋白分析平台的公司鸚鵡螺生物技術有限公司（納斯達克股票代碼：NAUT；或 “Nautilus”）今天宣佈，將在2024年4月30日星期二開市前公佈2024年第一季度的財務業績。
The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: www.nautilus.bio.
該公司的管理層將從太平洋時間上午 5:30 /美國東部時間上午 8:30 開始網絡直播相應的電話會議，討論其業績、業務發展和前景。網絡直播的直播音頻將在公司網站的 “投資者” 部分提供，網址爲： www.nautilus.bio。
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
關於鸚鵡螺生物技術有限公司
Nautilus是一家處於開發階段的生命科學公司，其公司總部位於華盛頓州西雅圖，研發總部位於加利福尼亞州的聖卡洛斯，致力於開發一種用於量化和解鎖蛋白質組複雜性的平台技術。Nautilus的使命是通過普及蛋白質組並實現人類健康和醫學領域的根本進步來改變蛋白質組學領域。要了解有關 Nautilus 的更多信息，請訪問 www.nautilus.bio。
Media Contact
press@nautilus.bio
媒體聯繫人
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
投資者聯繫人
investorrelations@nautilus.bio